Viewing Study NCT00644020


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:04 AM
Study NCT ID: NCT00644020
Status: UNKNOWN
Last Update Posted: 2008-03-26
First Post: 2008-03-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients
Sponsor: Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module